|
HY-10126-50mg
|
MedChemexpress LLC
|
Barasertib-HQPA [CAS 722544-51-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10127-10mg
|
MedChemexpress LLC
|
Barasertib [CAS 722543-31-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-10127-5mg
|
MedChemexpress LLC
|
Barasertib [CAS 722543-31-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-10127-50mg
|
MedChemexpress LLC
|
Barasertib [CAS 722543-31-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-10130-10mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-100mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-200mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-5mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-50mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-101529-10mg
|
MedChemexpress LLC
|
Imanixil [CAS 75689-93-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-101529-5mg
|
MedChemexpress LLC
|
Imanixil [CAS 75689-93-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-101893-50mg
|
MedChemexpress LLC
|
Dihydrofluorescein diacetate [CAS 35340-49-9]
|
|
|
|
|
HY-10264-10mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264-100mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264-5mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264-50mg
|
MedChemexpress LLC
|
Edoxaban [CAS 480449-70-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264A-10mg
|
MedChemexpress LLC
|
Edoxaban (tosylate) [CAS 480449-71-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264A-5mg
|
MedChemexpress LLC
|
Edoxaban (tosylate) [CAS 480449-71-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-10mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-100mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-5mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264B-50mg
|
MedChemexpress LLC
|
Edoxaban (tosylate monohydrate) [CAS 1229194-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-10264S-1mg
|
MedChemexpress LLC
|
Edoxaban-d6 [CAS 1304701-57-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10286-1mg
|
MedChemexpress LLC
|
Dutogliptin [CAS 852329-66-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10286-10mg
|
MedChemexpress LLC
|
Dutogliptin [CAS 852329-66-9]
|
|
Metabolism-protein/nucleotide metabolism
|
|
